146 related articles for article (PubMed ID: 36328436)
1. Use of the ISUP e-learning module improves interrater reliability in prostate cancer grading.
Flach RN; Egevad L; Eklund M; van der Kwast TH; Delahunt B; Samaratunga H; Suelmann BBM; Willemse PM; Meijer RP; van Diest PJ
J Clin Pathol; 2023 Dec; 77(1):22-26. PubMed ID: 36328436
[TBL] [Abstract][Full Text] [Related]
2. Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study.
Bulten W; Pinckaers H; van Boven H; Vink R; de Bel T; van Ginneken B; van der Laak J; Hulsbergen-van de Kaa C; Litjens G
Lancet Oncol; 2020 Feb; 21(2):233-241. PubMed ID: 31926805
[TBL] [Abstract][Full Text] [Related]
3. Expected impact of MRI-targeted biopsy interreader variability among uropathologists on ProScreen prostate cancer screening trial: a pre-trial validation study.
Hietikko R; Mirtti T; Kilpeläinen TP; Tolonen T; Räisänen-Sokolowski A; Nordling S; Hannus J; Laurila M; Taari K; Tammela TLJ; Autio R; Natunen K; Auvinen A; Rannikko A
World J Urol; 2024 Apr; 42(1):217. PubMed ID: 38581590
[TBL] [Abstract][Full Text] [Related]
4. Utility of Pathology Imagebase for standardisation of prostate cancer grading.
Egevad L; Delahunt B; Berney DM; Bostwick DG; Cheville J; Comperat E; Evans AJ; Fine SW; Grignon DJ; Humphrey PA; Hörnblad J; Iczkowski KA; Kench JG; Kristiansen G; Leite KRM; Magi-Galluzzi C; McKenney JK; Oxley J; Pan CC; Samaratunga H; Srigley JR; Takahashi H; True LD; Tsuzuki T; van der Kwast T; Varma M; Zhou M; Clements M
Histopathology; 2018 Jul; 73(1):8-18. PubMed ID: 29359484
[TBL] [Abstract][Full Text] [Related]
5. A comparison of interobserver reproducibility of Gleason grading of prostatic carcinoma in Japan and the United States.
Oyama T; Allsbrook WC; Kurokawa K; Matsuda H; Segawa A; Sano T; Suzuki K; Epstein JI
Arch Pathol Lab Med; 2005 Aug; 129(8):1004-10. PubMed ID: 16048389
[TBL] [Abstract][Full Text] [Related]
6. The impact of the 2005 International Society of Urological Pathology consensus guidelines on Gleason grading - a matched-pair analysis.
Berg KD; Thomsen FB; Nerstrøm C; Røder MA; Iversen P; Toft BG; Vainer B; Brasso K
BJU Int; 2016 Jun; 117(6):883-9. PubMed ID: 26823232
[TBL] [Abstract][Full Text] [Related]
7. The effect of an e-learning module on grading variation of (pre)malignant breast lesions.
van Dooijeweert C; Deckers IAG; de Ruiter EJ; Ter Hoeve ND; Vreuls CPH; van der Wall E; van Diest PJ
Mod Pathol; 2020 Oct; 33(10):1961-1967. PubMed ID: 32404951
[TBL] [Abstract][Full Text] [Related]
8. WHO/ISUP grading of clear cell renal cell carcinoma and papillary renal cell carcinoma; validation of grading on the digital pathology platform and perspectives on reproducibility of grade.
Browning L; Colling R; Verrill C
Diagn Pathol; 2021 Aug; 16(1):75. PubMed ID: 34419085
[TBL] [Abstract][Full Text] [Related]
9. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of an Artificial Intelligence-Powered Platform for Prostate Cancer Grading and Quantification.
Huang W; Randhawa R; Jain P; Iczkowski KA; Hu R; Hubbard S; Eickhoff J; Basu H; Roy R
JAMA Netw Open; 2021 Nov; 4(11):e2132554. PubMed ID: 34730818
[TBL] [Abstract][Full Text] [Related]
11. Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists.
Allsbrook WC; Mangold KA; Johnson MH; Lane RB; Lane CG; Amin MB; Bostwick DG; Humphrey PA; Jones EC; Reuter VE; Sakr W; Sesterhenn IA; Troncoso P; Wheeler TM; Epstein JI
Hum Pathol; 2001 Jan; 32(1):74-80. PubMed ID: 11172298
[TBL] [Abstract][Full Text] [Related]
12. International Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary grading.
Egevad L; Delahunt B; Srigley JR; Samaratunga H
APMIS; 2016 Jun; 124(6):433-5. PubMed ID: 27150257
[TBL] [Abstract][Full Text] [Related]
13. Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists.
Bulten W; Balkenhol M; Belinga JA; Brilhante A; Çakır A; Egevad L; Eklund M; Farré X; Geronatsiou K; Molinié V; Pereira G; Roy P; Saile G; Salles P; Schaafsma E; Tschui J; Vos AM; ; van Boven H; Vink R; van der Laak J; Hulsbergen-van der Kaa C; Litjens G
Mod Pathol; 2021 Mar; 34(3):660-671. PubMed ID: 32759979
[TBL] [Abstract][Full Text] [Related]
14. Inter-observer reproducibility before and after web-based education in the Gleason grading of the prostate adenocarcinoma among the Iranian pathologists.
Abdollahi A; Sheikhbahaei S; Meysamie A; Bakhshandeh M; Hosseinzadeh H
Acta Med Iran; 2014; 52(5):370-4. PubMed ID: 24902017
[TBL] [Abstract][Full Text] [Related]
15. Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.
Roobol MJ; Verbeek JFM; van der Kwast T; Kümmerlin IP; Kweldam CF; van Leenders GJLH
Eur Urol; 2017 Jul; 72(1):45-51. PubMed ID: 28162815
[TBL] [Abstract][Full Text] [Related]
16. Deep Learning-Based Gleason Grading of Prostate Cancer From Histopathology Images-Role of Multiscale Decision Aggregation and Data Augmentation.
Karimi D; Nir G; Fazli L; Black PC; Goldenberg L; Salcudean SE
IEEE J Biomed Health Inform; 2020 May; 24(5):1413-1426. PubMed ID: 31567104
[TBL] [Abstract][Full Text] [Related]
17. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study.
Ström P; Kartasalo K; Olsson H; Solorzano L; Delahunt B; Berney DM; Bostwick DG; Evans AJ; Grignon DJ; Humphrey PA; Iczkowski KA; Kench JG; Kristiansen G; van der Kwast TH; Leite KRM; McKenney JK; Oxley J; Pan CC; Samaratunga H; Srigley JR; Takahashi H; Tsuzuki T; Varma M; Zhou M; Lindberg J; Lindskog C; Ruusuvuori P; Wählby C; Grönberg H; Rantalainen M; Egevad L; Eklund M
Lancet Oncol; 2020 Feb; 21(2):222-232. PubMed ID: 31926806
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Prostate Cancer in PI-RADS Version 2.1 Transition Zone Atypical Nodules Upgraded by Abnormal DWI: Correlation With MRI-Directed TRUS-Guided Targeted Biopsy.
Lim CS; Abreu-Gomez J; Carrion I; Schieda N
AJR Am J Roentgenol; 2021 Mar; 216(3):683-690. PubMed ID: 32755208
[No Abstract] [Full Text] [Related]
19. Predictive value of the 2014 International Society of Urological Pathology grading system for prostate cancer in patients undergoing radical prostatectomy with long-term follow-up.
Grogan J; Gupta R; Mahon KL; Stricker PD; Haynes AM; Delprado W; Turner J; Horvath LG; Kench JG
BJU Int; 2017 Nov; 120(5):651-658. PubMed ID: 28371244
[TBL] [Abstract][Full Text] [Related]
20. Standardization of Gleason grading among 337 European pathologists.
Egevad L; Ahmad AS; Algaba F; Berney DM; Boccon-Gibod L; Compérat E; Evans AJ; Griffiths D; Grobholz R; Kristiansen G; Langner C; Lopez-Beltran A; Montironi R; Moss S; Oliveira P; Vainer B; Varma M; Camparo P
Histopathology; 2013 Jan; 62(2):247-56. PubMed ID: 23240715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
